Amit V Pandey
Also known as: Amit Vikram Pandey, AV Pandey, A Vikram Pandey
Inselspital Universitätsspital Bern, Universität Bern, UCSF Medical Center, Central Drug Research Institute, Universitat Bern, University of Lucknow Faculty of Science
About
Prof. Dr. Amit V. Pandey is a Professor at the Department of Pediatrics, University of Bern, and Group Leader of the Translational Hormone Research Program at the University Children’s Hospital Bern, Switzerland. A distinguished molecular biologist, he specializes in the structural biology, enzymology, and genetics of steroidogenesis and human metabolic disorders.
Professor Pandey obtained his PhD from the Central Drug Research Institute (CDRI), Lucknow, India, and completed his postdoctoral training at the University of California, San Francisco (UCSF) with Prof. Walter L. Miller. At UCSF, he played a pivotal role in elucidating the molecular basis of P450 Oxidoreductase (POR) deficiency and the regulation of androgen biosynthesis by Cytochrome P450 enzyme CYP17A1.
Since establishing his laboratory in Bern in 2007, his research has focused on the "bench-to-bedside" characterization of genetic variations in Cytochrome P450 enzymes and their redox partners. His group employs computational modeling, enzyme kinetics, and cellular assays to understand how genetic mutations drive conditions such as Congenital Adrenal Hyperplasia (CAH), Polycystic Ovary Syndrome (PCOS), and Prostate Cancer. Key contributions include the development of structure-guided inhibitors for CYP17A1 and the discovery of novel pharmacogenomic markers in POR that influence drug metabolism.
Professor Pandey's research is supported by the Swiss National Science Foundation (SNSF), Cancer Research Switzerland, and major industry partners. He has authored over 120 peer-reviewed publications (H-index 44, >7600 citations) in journals including Nature Genetics, Nature Communications, American Journal of Human Genetics, Journal of Biological Chemistry, and the Journal of Clinical Endocrinology and Metabolism (JCEM). He has also written authoritative reviews in Pharmacology & Therapeutics, as well for Elsevier Encyclopedia of Endocrinology, and prestigious Books in the field of Endocrinology. He served as the Conference Chair for the 24th International Conference on Cytochrome P450, ICCP450 (2025) and holds editorial positions at Frontiers in Pharmacology, Frontiers in Endocrinology, IUBMB Life, and Endocrine Connections. He is a recipient of the Servier Research Award and the Young Investigator Award from the Swiss Society for Endocrinology & Diabetology.
Research Interests: Molecular Endocrinology, P450 Oxidoreductase (POR), CYP17A1, Prostate Cancer Drug Discovery, Pharmacogenomics, Structural Biology, and Precision Medicine.
Employment
-
Inselspital Universitätsspital Bern Privatdozent and Group Leader2014 - Present
-
Universität Bern Principal Investigator2007 - Present
-
Universität Bern Research Associate2005 - 2007
-
UCSF Medical Center Postdoctoral Fellow2000 - 2005
-
Universitat Bern
Education
-
UCSF Medical Center Endocrinology2000 - 2005
-
Central Drug Research Institute PhD1993 - 1997
-
University of Lucknow Faculty of Science MSc1990 - 1992
-
University of Lucknow Faculty of Science BSc1987 - 1990
Projects & Funding
Projects & funding information is unavailable.
Publications (239)
- Analysis of androgen modulation by natural products Save
- Catalytic Partitioning and Divergent Steroidogenic Effects of CYP17A1 Inhibition by Seviteronel and Abiraterone Save
- Catalytic partitioning and divergent steroidogenic effects of CYP17A1 inhibition by seviteronel and abiraterone Save
- Analysis of androgen modulation by natural products. Save
- Complete POR ablation in human adrenal cells reveals steroidogenic rerouting and variant-dependent loss of cytochrome P450 support Save
- Precursor-dependent steroid conversion sustains androgen receptor signaling and lineage-state divergence in prostate cancer Save
- Integrated mapping resolves pathogenicity of 11 CYP21A2 variants in congenital adrenal hyperplasia. Save
- Integrated mapping resolves pathogenicity of 11 CYP21A2 variants in congenital adrenal hyperplasia Save
- Clinical hurdles for curcumin and piperine nanoparticles in prostate cancer treatment: a bridge too far or a path to clinical reality? Save
- Complete Genomic Ablation of Cytochrome P450 Oxidoreductase Unveils Endogenous Steroidogenic Shunting and Variant Instability Save